Related references
Note: Only part of the references are listed.Predictors of survival trajectories among women with epithelial ovarian cancer
Lauren C. Peres et al.
GYNECOLOGIC ONCOLOGY (2020)
Association of Powder Use in the Genital Area With Risk of Ovarian Cancer
Katie M. O'Brien et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
Catherine de Martel et al.
LANCET GLOBAL HEALTH (2020)
Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohort
Annika Idahl et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Clearance ofMycoplasma genitaliumandTrichomonas vaginalisAmong Adolescents and Young Adults With Pelvic Inflammatory Disease: Results From the Tech-N Study
Maria Trent et al.
SEXUALLY TRANSMITTED DISEASES (2020)
Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations
Britton Trabert et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations
Britton Trabert et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Sexually transmitted infections and risk of epithelial ovarian cancer: results from the Nurses' Health Studies
Renee T. Fortner et al.
BRITISH JOURNAL OF CANCER (2019)
Mucinous Ovarian Carcinoma
Philippe Morice et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Chronic Chlamydia infection in human organoids increases stemness and promotes age-dependent CpG methylation
Mirjana Kessler et al.
NATURE COMMUNICATIONS (2019)
Integrated Phosphoproteome and Transcriptome Analysis Reveals Chlamydia-Induced Epithelial-to-Mesenchymal Transition in Host Cells
Piotr K. Zadora et al.
CELL REPORTS (2019)
The molecular origin and taxonomy of mucinous ovarian carcinoma
Dane Cheasley et al.
NATURE COMMUNICATIONS (2019)
Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma
Shuang Zhang et al.
NATURE COMMUNICATIONS (2019)
Chlamydia trachomatis impairs host base excision repair by downregulating polymerase β
Nitish Gulve et al.
CELLULAR MICROBIOLOGY (2019)
Advancing the public health applications of Chlamydia trachomatis serology
Sarah C. Woodhall et al.
LANCET INFECTIOUS DISEASES (2018)
Chlamydia trachomatis, Chlamydial Heat Shock Protein 60 and Anti-Chlamydial Antibodies in Women with Epithelial Ovarian Tumors
Sarah Jonsson et al.
TRANSLATIONAL ONCOLOGY (2018)
Sera selected from national STI surveillance system shows Chlamydia trachomatis PgP3 antibody correlates with time since infection and number of previous infections
Paula B. Blomquist et al.
PLoS One (2018)
Chlamydia trachomatis Inhibits Homologous Recombination Repair of DNA Breaks by Interfering with PP2A Signaling
Yang Mi et al.
MBIO (2018)
Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies
Christina B. Rasmussen et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2017)
Is Pelvic Inflammatory Disease a Risk Factor for Ovarian Cancer?
Christina B. Rasmussen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Antibody to Chlamydia trachomatis proteins, TroA and HtrA, as a biomarker for Chlamydia trachomatis infection
K. Hokynar et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
International patterns and trends in ovarian cancer incidence, overall and by histologic subtype
S. B. Coburn et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Microbial infection, inflammation and epithelial ovarian cancer
Xiaohui Xie et al.
ONCOLOGY LETTERS (2017)
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma
Jennifer Ducie et al.
NATURE COMMUNICATIONS (2017)
High grade serous ovarian carcinomas originate in the fallopian tube
S. Intidhar Labidi-Galy et al.
NATURE COMMUNICATIONS (2017)
Epidemiology of ovarian cancer: a review
Brett M. Reid et al.
CANCER BIOLOGY & MEDICINE (2017)
Pelvic inflammatory disease and the risk of ovarian cancer: a meta-analysis
Zhiyi Zhou et al.
CANCER CAUSES & CONTROL (2017)
The Dualistic Model of Ovarian Carcinogenesis Revisited, Revised, and Expanded
Robert J. Kurman et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Inflammatory Markers of CRP, IL6, TNFα, and Soluble TNFR2 and the Risk of Ovarian Cancer: A Meta-analysis of Prospective Studies
Fangfang Zeng et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium
Nicolas Wentzensen et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Pelvic Inflammatory Disease
Robert C. Brunham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study
Cecilie Madsen et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2015)
Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting
Lori Newman et al.
PLOS ONE (2015)
The sensitivity and specificity of transvaginal ultrasound with regard to acute pelvic inflammatory disease: a review of the literature
G. Romosan et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2014)
Aspirin, Nonaspirin Nonsteroidal Anti-inflammatory Drug, and Acetaminophen Use and Risk of Invasive Epithelial Ovarian Cancer: A Pooled Analysis in the Ovarian Cancer Association Consortium
Britton Trabert et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors
Christina B. Rasmussen et al.
CANCER CAUSES & CONTROL (2013)
Genital Powder Use and Risk of Ovarian Cancer: A Pooled Analysis of 8,525 Cases and 9,859 Controls
Kathryn L. Terry et al.
CANCER PREVENTION RESEARCH (2013)
Chlamydia Infection Promotes Host DNA Damage and Proliferation but Impairs the DNA Damage Response
Cindrilla Chumduri et al.
CELL HOST & MICROBE (2013)
Pelvic Inflammatory Disease: Identifying Research Gaps-Proceedings of a Workshop Sponsored by Department of Health and Human Services/National Institutes of Health/National Institute of Allergy and Infectious Diseases, November 3-4, 2011
Toni Darville
SEXUALLY TRANSMITTED DISEASES (2013)
Chlamydia trachomatis infections of the female genital tract: State of the art
Jorma Paavonen
ANNALS OF MEDICINE (2012)
Aspirin, Nonaspirin Nonsteroidal Anti-inflammatory Drugs, or Acetaminophen and Risk of Ovarian Cancer
Wei-Hsuan Lo-Ciganic et al.
EPIDEMIOLOGY (2012)
Effect of IL12A and IL12B polymorphisms on the risk of Chlamydia trachomatis-induced tubal factor infertility and disease severity
H. Ohman et al.
HUMAN REPRODUCTION (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-Shifting the paradigm
Robert J. Kurman et al.
HUMAN PATHOLOGY (2011)
Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study
Hui-Wen Lin et al.
LANCET ONCOLOGY (2011)
Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, human papillomavirus, and polyomavirus are not detectable in human tissue with epithelial ovarian cancer, borderline tumor, or benign conditions
Annika Idahl et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Robert J. Kurman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Inflammation A hidden path to breaking the spell of ovarian cancer
Weiwei Shan et al.
CELL CYCLE (2009)
Pgp3 Antibody Enzyme-Linked Immunosorbent Assay, a Sensitive and Specific Assay for Seroepidemiological Analysis of Chlamydia trachomatis Infection
Gillian S. Wills et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Inflammation and cancer: An ancient link with novel potentials
S. Perwez Hussain et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Immunology of Chlamydia infection:: Implications for a Chlamydia trachomatis vaccine
RC Brunham et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes -: implications for cost-effectiveness analyses
IGM van Valkengoed et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2004)
Serologic evidence of past infection with Chlamydia trachomatis, in relation to ovarian cancer
RB Ness et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Transvaginal power Doppler findings in laparoscopically proven acute pelvic inflammatory disease
P Molander et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2001)
Share Paper
